Viridans group streptococci are a collection of bacterial species that live quietly in the mouth, throat, and genital tract of healthy people, and for decades, finding them in a urine culture usually meant a lab technician shrugged and wrote “probable contaminant.” That assumption is increasingly under scrutiny. Research now shows that certain viridans species can genuinely colonize the bladder, trigger immune responses in the urinary tract, and cause complicated or recurring infections, particularly in people with catheters, structural urinary problems, or weakened immune defenses. Understanding which species matter, how they gain a foothold, and what can be done about them fills a gap that standard UTI advice rarely addresses.
What Viridans Group Streptococci Actually Are
Viridans group streptococci (VGS) is not one species but a broad umbrella covering dozens of related streptococcal species. The name “viridans” comes from the Latin for “green,” a reference to the greenish hue some of them produce when grown on blood agar plates in a lab. Common members include species within the S. mitis group, S. anginosus group, S. sanguinis group, S. salivarius group, and S. mutans group. Early clinical surveys found that the most frequently isolated strains belonged to S. milleri, S. mitis, S. sanguis I, and S. sanguis II.1PubMed. Distribution and incidence of viridans streptococcal species in routine clinical specimens These bacteria are part of the normal flora of the human mouth and upper respiratory tract, and some colonize the gastrointestinal and urogenital tracts as well.
Most viridans streptococci behave as commensals, living on and in us without causing harm. Their medical reputation rests mainly on two things: dental cavities (S. mutans is a primary driver) and infective endocarditis, where oral viridans species enter the bloodstream and settle on damaged heart valves. The idea that they could also be meaningful urinary pathogens is relatively new, and it clashes with the standard clinical reflex of dismissing them when they turn up in urine cultures.
Why They Were Long Dismissed in Urine Cultures
Traditional urine culture methods are optimized to detect the usual UTI culprits, above all E. coli, which causes the majority of uncomplicated urinary infections. Standard protocols typically use aerobic culture on selective media at set thresholds, and anything that doesn’t fit the expected profile of a gram-negative rod is easy to write off. Viridans streptococci, being gram-positive cocci, look out of place. Because they live in the genital and perineal area, a positive result was routinely attributed to contamination during specimen collection rather than to genuine bladder infection.
That logic had a practical basis: voided urine samples do pick up bacteria from the skin and mucous membranes on the way out. But newer research has complicated the picture. In a study of older adults with clinically suspected complicated UTIs, VGS were detected not only in midstream voided specimens but also in urine collected directly from the bladder via catheter, eliminating the contamination argument. The same specimens showed elevated markers of immune activation in the urinary tract, meaning the body was actively fighting the bacteria, not passively tolerating a stray organism.2Pathnostics. Viridans Group Streptococci This was strong evidence that VGS were genuinely infecting the bladder, not just passing through.
Which Species Cause Urinary Infections
Not all viridans streptococci are equally likely to cause UTIs. The species most consistently implicated are S. anginosus, S. oralis, and S. pasteuranus. Each has a distinct clinical profile, but they share a tendency to show up in complicated, persistent, or recurrent urinary infections rather than simple one-off cystitis.
S. anginosus is one of the better-studied culprits. Genetic sequencing has confirmed that virtually identical strains of S. anginosus can be found in both the vagina and bladder of the same individual, consistent with the known cross-talk between vaginal and urinary microbiomes. In women with lower urinary tract disorders, including interstitial cystitis and bladder pain syndrome, S. anginosus has been identified in catheter-collected urine at higher densities and more frequently than in urine from women without symptoms. This suggests it may act as an opportunistic pathogen that takes advantage of a disrupted urogenital microbiome.2Pathnostics. Viridans Group Streptococci
S. pasteuranus, which belongs to the S. bovis subgroup, has been linked to complicated, persistent, and recurrent UTIs in specific populations: newborns, older adults, pregnant women, and immunocompromised individuals.2Pathnostics. Viridans Group Streptococci S. mitis, meanwhile, has been documented as a rare but real cause of catheter-associated UTI. One reported case involved a 65-year-old man with an enlarged prostate and chronic urinary retention who required a long-term indwelling catheter, and his UTI was traced to S. mitis.3PubMed Central. Streptococcus mitis: An Unusual Causative Agent for Urinary Tract Infection
Who Is Most at Risk
VGS urinary infections are not something most healthy people need to worry about. They cluster heavily among people with identifiable risk factors that either compromise the body’s normal defenses or provide the bacteria with a physical gateway into the urinary tract.
The biggest risk factor is catheterization. An indwelling urinary catheter bypasses the body’s natural barriers, provides a surface for bacteria to cling to, and creates a direct route from the outside world into the bladder. Patients who require chronic catheterization are disproportionately represented in VGS UTI case reports. Beyond catheters, other risk factors include urinary tract abnormalities (strictures, stones, or structural problems that impair normal urine flow), immunosuppressive conditions, and recent urological procedures such as ureteroscopy.4Translational Research in Urology. Rare Urinary Tract Infection with Streptococcus Mitis/Oralis following Ureteroscopy in a Patient with Urinary Stones and Ureteral Stenosis
Age also matters. Older adults appear more susceptible, possibly because of the higher prevalence of structural urinary issues, catheter use, and weakened immunity in that population. Neonates represent another vulnerable group, with S. pasteuranus infections documented in very young infants. Pregnant women also carry a higher burden of vaginal VGS colonization: in one study of 482 pregnant women, about 30% were culture-positive for viridans streptococci, and colonization was more common among women with bacterial vaginosis than among those with normal vaginal flora.5PubMed Central. Association of viridans group streptococci from pregnant women with bacterial vaginosis and upper genital tract infection
How They Gain a Foothold in the Urinary Tract
VGS are not powerless hitchhikers. They carry a toolkit of virulence traits that help them attach to human tissue, invade cells, and evade immune defenses. Much of what is known about these traits comes from studies of VGS in other contexts, particularly endocarditis, but the same mechanisms are relevant to urinary tract colonization.
Attachment is the first step. Electron microscopy of viridans streptococci interacting with human endothelial cells has revealed bacteria latching onto cell surfaces via numerous fibrillar structures and then being taken up into membrane-enclosed vacuoles inside the cell. Several surface proteins are involved: a glucosyltransferase enzyme, a sialic acid-binding protein called Hsa, and proteins that influence hydrophobicity and coaggregation (CshA and CshB). All of these contribute to the bacterium’s ability to invade host cells effectively.6PubMed Central. Invasion and killing of human endothelial cells by viridans group streptococci
A shared genetic signature may also help explain why certain VGS species are better at invading tissue. Researchers have identified a recurring protein motif, dubbed MiiA, that appears in surface proteins of multiple VGS species as well as other bacteria found in the urogenital tract and mouth. This motif is associated with invasive disease and likely plays a role in binding to sugars on the surface of epithelial and blood cells, essentially helping the bacterium “dock” onto host tissue.7PubMed. The MiiA motif is a common marker present in polytopic surface proteins of oral and urinary tract invasive bacteria
Biofilm formation adds another layer. Viridans streptococci are known biofilm producers, meaning they can form structured, sticky communities on surfaces such as catheters and damaged tissue. Biofilms make bacteria far harder to eradicate because they shield the organisms from both antibiotics and the immune system. Research on VGS biofilms in atherosclerotic plaques has shown that these biofilms can go unrecognized by macrophages, the immune cells normally responsible for detecting and destroying invaders.8PubMed Central. Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic Plaques The ability to hide in plain sight inside a biofilm likely helps explain why VGS infections in the urinary tract can become chronic and recurrent.
Metabolic Versatility and Sugar Scavenging
Part of what allows VGS to thrive in different body sites is a remarkable ability to extract nutrients from human glycoproteins, the sugar-coated proteins found on cell surfaces and in body fluids. Several viridans species produce enzymes called glycosidases that strip sugars from these glycoproteins and use them as fuel. S. oralis, for instance, produces a suite of enzymes including sialidase, beta-galactosidase, and several mannosidases that allow it to dismantle the sugar chains of human serum glycoproteins in unusual depth. S. intermedius takes a somewhat different enzymatic route but achieves a similar result, breaking down glycoprotein sugars and consuming them for growth.9PubMed. Growth of Viridans streptococci on human serum alpha1-acid glycoprotein
This metabolic flexibility matters for UTIs because the urinary tract is not a nutrient-rich environment. A bacterium that can scavenge sugar from the host’s own tissues and secretions has a survival advantage in a setting where other organisms might starve. It also means that VGS don’t necessarily need to rely on dietary sugars reaching the urine; they can feed on what the body produces locally.
Complications Beyond the Bladder
One reason VGS UTIs deserve serious attention is that they can, in vulnerable patients, lead to severe systemic complications. S. anginosus urinary infections have been linked to bacteremia (bacteria entering the bloodstream) and endocarditis (infection of the heart valves). S. oralis UTIs carry a risk of bacteremia, peritonitis, endocarditis, and even meningitis. S. pasteuranus infections may result in bacteremia, endocarditis, meningitis, and sepsis.10Pathnostics UTI Knowledge Center. Viridans Group Streptococci
These complications are not common outcomes of a simple VGS UTI, but they are well-documented. The risk is highest in people who are already medically fragile: the immunosuppressed, the very old, the very young, and those with pre-existing heart valve abnormalities. For these patients, a VGS-positive urine culture that might otherwise be dismissed as contamination could be a warning sign that deserves follow-up.
Antibiotic Susceptibility and Resistance Trends
Treating a confirmed VGS UTI is not always straightforward because resistance patterns vary substantially across species. A large U.S. surveillance study covering 2010 to 2020 found that VGS remained broadly susceptible to ceftriaxone (96% to 100% depending on species) and vancomycin (over 99%). Penicillin susceptibility, however, was more variable: about 71% of S. mitis isolates were susceptible, compared with about 81% of S. oralis and 86% of unspeciated VGS. Over the decade studied, susceptibility to clindamycin decreased significantly among unspeciated VGS, and susceptibility to erythromycin dropped significantly among S. mitis.11PubMed Central. Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020
A separate study examining species-level resistance patterns found even more striking variation. The S. salivarius group showed the highest rate of reduced penicillin susceptibility, at about 79%, while the S. anginosus group had the lowest, at roughly 6%. The S. mitis group fell in between, with about 60% of isolates showing reduced susceptibility to penicillin.12PubMed Central. Species-specific difference in antimicrobial susceptibility among viridans group streptococci This variation makes accurate species identification important, because the right antibiotic depends on which viridans species you’re dealing with.
The Diagnostic Challenge
Identifying VGS to the species level has historically been difficult, which is part of why these organisms have been underappreciated as uropathogens. Traditional biochemical identification methods can speciate roughly 97% of clinical VGS isolates based on stable enzymatic reactions, but the process is labor-intensive.13PubMed Central. Physiological differentiation of viridans streptococci Newer technology has helped: MALDI-TOF mass spectrometry, which identifies bacteria by their protein fingerprint, has become a workhorse in clinical labs. However, it still struggles to distinguish between closely related species within certain groups, particularly the S. mitis group. Gene sequencing of targets like tuf, sodA, and rpoB provides more reliable discrimination but is not available in every clinical laboratory.14PLoS ONE. Viridans Group Streptococci Clinical Isolates: MALDI-TOF Mass Spectrometry versus Gene Sequence-Based Identification
Expanded quantitative urine culture (EQUC), a technique that uses more media types, longer incubation, and lower detection thresholds than standard culture, has been instrumental in revealing VGS in urine specimens that standard methods would have missed. Much of the recent clinical evidence linking VGS to UTIs comes from studies using EQUC or similar enhanced culture techniques. If your urine was cultured only with standard methods and reported “no growth” or “mixed flora,” a VGS infection could have been present but undetected.
Prevention Strategies
Preventing VGS UTIs overlaps substantially with preventing catheter-associated urinary tract infections (CAUTIs) in general, since catheter use is the single biggest risk factor. The core principles are well established: minimize the use of urinary catheters, remove them as early as clinically appropriate, and avoid inserting unnecessary ones in the first place. Training of nursing staff on current catheter care guidelines and reducing antibiotic use unless genuinely needed are also effective measures for lowering CAUTI rates.15PubMed Central. Catheter-Associated Urinary Tract Infections in the Adult Patient Group: A Qualitative Systematic Review on the Adopted Preventative and Interventional Protocols From the Literature
Beyond catheter management, other prevention considerations include:
- Addressing structural problems: Urinary stones, strictures, and obstructions create stagnant urine and damaged tissue where VGS can settle. Treating the underlying structural issue removes the ecological niche.
- Supporting a healthy urogenital microbiome: Because S. anginosus colonization of the bladder appears linked to disruption of the normal vaginal and urinary microbiome, maintaining healthy vaginal flora through established strategies (avoiding douching, treating bacterial vaginosis promptly) may help keep opportunistic VGS in check.
- Careful post-procedure monitoring: People who undergo urological procedures such as ureteroscopy and who have pre-existing risk factors should be monitored for signs of infection in the days and weeks afterward.
There is no VGS-specific vaccine or prophylactic regimen for UTIs. Prevention is fundamentally about reducing the opportunities for these opportunistic bacteria to access the urinary tract and find conditions favorable for growth.
VGS in Pregnancy
Pregnant women warrant special mention because vaginal colonization with viridans streptococci is common during pregnancy and because UTIs in pregnancy carry higher stakes. In the study of 482 pregnant women mentioned earlier, vaginal VGS colonization was found in about 30% of participants overall, rising to 41% among women with bacterial vaginosis. The most frequently isolated vaginal species was S. intermedius, followed by S. acidominimus and S. constellatus. Critically, viridans streptococci were also recovered from amniotic fluid and placental cultures, indicating that vaginal colonization can lead to ascending infection.5PubMed Central. Association of viridans group streptococci from pregnant women with bacterial vaginosis and upper genital tract infection
This does not mean that every pregnant woman colonized with VGS will develop problems, but it does mean that VGS should not be automatically ignored in prenatal urine cultures, particularly in the presence of symptoms. The tendency to dismiss these organisms as contaminants may carry real consequences when ascending infection is a possibility.
When a Positive Culture Should Not Be Ignored
The shift in thinking about VGS and UTIs boils down to a practical question for clinicians and patients alike: when should a positive VGS urine culture be taken seriously? There is no universal guideline yet, but the emerging consensus from the research points to a few red flags. If VGS are found in catheter-collected urine (which eliminates the contamination explanation), if the patient has symptoms consistent with UTI, if there are elevated inflammatory markers in the urine, or if the patient has known risk factors such as immunosuppression, structural abnormalities, or a history of recurrent infections, then dismissing the result as a contaminant is harder to justify. The same applies when VGS turn up repeatedly in cultures from the same patient, since persistence suggests genuine colonization rather than accidental contamination.
For patients who keep getting told their VGS-positive cultures are “nothing to worry about” yet continue to have urinary symptoms, asking about enhanced culture methods such as EQUC and requesting species-level identification can be a productive conversation to have with a urologist or infectious disease specialist. The science has moved faster than the clinical defaults in this area, and awareness of VGS as genuine uropathogens is still catching up in everyday practice.